---
title: Lung Cancer Screening And Diagnosis
draft: true
---

## What this covers
- Trials
- Guidelines
- Shared decision-making

## Learning objectives
- Trials
- Guidelines
- Shared decision-making
- Absolute benefits and harms
- Sensitivity to imaging follow-up algorithms?
- Diagnosis and Staging
- Tumor Markers:

## Bottom line / summary
- Mar 2021 USPSTF update -> age now 55->50 to 80; minimum pack years 30->20 and quit within the last 15 years.
- https://jamanetwork.com/journals/jama/fullarticle/2777244
- Prediction model - https://www.atsjournals.org/doi/pdf/10.1164/rccm.202104-1009ED
- PLCOm2012 is another prediction score
- The eligibility criteria are another inherent prediction model

## Approach
1. notably, they state that ~10% of eligible patients currently get screened. Authors state 50% might be reasonable (not clear what this is based on)
2. Lung Cancer Screening and Diagnosis
3. Trials

## Red flags / when to escalate
- TODO: List red flags that require urgent escalation.

## Common pitfalls
- TODO: Capture common errors or missed steps.

## References
- https://jamanetwork.com/journals/jama/fullarticle/2777244
- https://www.atsjournals.org/doi/pdf/10.1164/rccm.202104-1009ED

## Source notes

### Lung Cancer Screening And Diagnosis
{{< include "../../archive/Clinical Practice Notes/lung-cancer-screening-and-diagnosis.md" >}}

## Source materials
- [Clinical Practice Notes/lung-cancer-screening-and-diagnosis.md](../../archive/Clinical%20Practice%20Notes/lung-cancer-screening-and-diagnosis.md)
